Maxlinear SEC Filings

MaxLinear, Inc. (MXL) reported Q3 2025 results showing higher sales and narrower losses. Net revenue reached $126.5 million versus $81.1 million a year ago, lifting gross profit to $71.9 million. Operating expenses were $113.2 million, including $11.3 million in restructuring charges, resulting in a loss from operations of $41.3 million. Net loss improved to $45.5 million (basic and diluted EPS $(0.52)) from $75.8 million (EPS $(0.90)$) in Q3 2024.

For the nine months, revenue was $331.2 million with a net loss of $121.8 million. Cash, cash equivalents and restricted cash totaled $113.3 million at quarter‑end, alongside $125.0 million of term debt maturing in 2028 (weighted average effective rate ~7.0%). Operating cash flow turned positive at $9.2 million year‑to‑date, aided by working capital movements. Stockholders’ equity was $464.7 million. As of October 15, 2025, MaxLinear had 87,372,834 common shares outstanding.

MaxLinear, Inc. filed an 8-K to report that it issued a press release announcing its unaudited financial results for the third quarter ended September 30, 2025. The press release is furnished as Exhibit 99.1 and incorporated by reference.

The company states the information is being furnished under Item 2.02 and shall not be deemed filed for purposes of Section 18 of the Exchange Act. It will only be incorporated by reference in other filings if expressly set forth. The filing also lists the Cover Page Interactive Data File as Exhibit 104.

Greg Dougherty, a director of MaxLinear, Inc. (MXL), amended his Form 4 to report an award of 15,741 restricted stock units (RSUs) granted with a transaction date of 05/20/2025. Each RSU converts to one share of common stock and the award was reported at a price of $0 because RSUs are not purchased. The amendment corrects the number of RSUs previously reported on 05/22/2025. The RSUs vest 100% on the earlier of 05/01/2026 or the date immediately preceding the next annual meeting of stockholders, provided the reporting person remains a director. Following the award, the reporting person beneficially owns 15,741 shares directly.

MaxLinear, Inc. (MXL) filed an amended Form 4 disclosing a grant of 15,741 restricted stock units (RSUs) to director Albert J. Moyer. The RSUs were granted on 05/20/2025 and each RSU represents a contingent right to one share of common stock. The amendment corrects the number of RSUs reported in the initial Form 4 filed 05/22/2025. The RSUs vest 100% on the earlier of 05/01/2026 or the date immediately preceding the next annual meeting of stockholders, provided the reporting person continues as a director. Following the award, Mr. Moyer beneficially owns 15,741 shares directly.

MaxLinear, Inc. director Carolyn Beaver amended her Form 4 to report the grant of 15,741 restricted stock units (RSUs) on 05/20/2025. Each RSU converts into one share of common stock and the award was reported with an exercise/price of $0, indicating a time‑based compensation award rather than a purchase. The amendment corrects the previously reported RSU count from the Form 4 filed 05/22/2025. Vesting is contingent on continued service as a director: 100% of the RSUs vest on the earlier of 05/01/2026 or the day before the next annual meeting of stockholders.

Thomas E. Pardun, a director of MaxLinear, Inc. (MXL), amended a Form 4 to report an award of 15,741 restricted stock units (RSUs) granted on 05/20/2025. Each RSU converts to one share of common stock and was reported with a zero grant price.

The RSUs vest 100% on the earlier of 05/01/2026 or the day immediately before the next annual meeting of stockholders, provided the reporting person remains a director. Following the reported transaction the reporting person beneficially owns 15,741 shares directly. The amendment corrects the number of RSUs previously reported on 05/22/2025.

MaxLinear, Inc. director Daniel A. Artusi amended a Form 4 to report receipt of 15,741 restricted stock units (RSUs) granted on 05/20/2025. Each RSU converts to one share of common stock on vesting. The amendment corrects the originally reported RSU count from the Form 4 filed 05/22/2025. The award vests 100% on the earlier of 05/01/2026 or immediately before the next annual meeting, but only if the reporting person remains a director through that date. Following the grant, Mr. Artusi beneficially owns 15,741 shares represented by these RSUs, held directly and reported at a price of $0 per unit (no cash purchase). The filing is dated and signed by an attorney-in-fact on 10/10/2025.

MaxLinear, Inc. director Ted L. Tewksbury III amended his earlier Form 4 to report an award of 15,741 restricted stock units (RSUs). Each RSU converts to one share of common stock and the amendment corrects the previously reported RSU count. The RSUs were granted on 05/20/2025 and are subject to a single vesting event: 100% vesting on the earlier of 05/01/2026 or the day before the next annual shareholders meeting, provided the reporting person remains a director. Following the reported transaction the reporting person beneficially owns 15,741 shares directly. The filing is an amendment to the Form 4 filed on 05/22/2025 and was signed by an attorney-in-fact on 10/10/2025.

MaxLinear insider Connie Kwong reported receipt of shares from RSU vesting and related withholdings. On 09/01/2025 Ms. Kwong received 58,909 shares of MaxLinear common stock as restricted stock units settled upon vesting. The filing also shows 58,152 shares were disposed of at a reported price of $15.72 (reflecting shares withheld to satisfy tax/withholding obligations). After the transactions, Ms. Kwong directly beneficially owns the delivered shares and retains 2,126 RSUs that remain subject to future vesting through August 20, 2026.